Stock LQDA LIQUIDIA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Liquidia Corporation

Equities

LQDA

US53635D2027

Real-time Estimate Cboe BZX
Other stock markets
 12:40:25 2024-05-13 EDT 		5-day change 1st Jan Change
12.26 USD +1.66% Intraday chart for Liquidia Corporation -3.31% +2.00%
04-01 Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension MT
04-01 Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling DJ

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Liquidia Announces Poster Presentation at the American Thoracic Society 2024 International Conference on Its Open-Label Safety Study of L606 in Patients with PAH and PH-ILD
AQ
Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD
GL
Liquidia Corporation to Present at BofA Securities Health Care Conference 2024
GL
Liquidia Corporation to Present at BofA Securities Health Care Conference 2024
AQ
Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024
GL
Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024
AQ
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference
GL
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference
AQ
Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension
MT
Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling
DJ
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
GL
Liquidia Insider Sold Shares Worth $452,183, According to a Recent SEC Filing
MT
Liquidia Corporation(NasdaqCM:LQDA) added to S&P Pharmaceuticals Select Industry Index
CI
HC Wainwright Adjusts Price Target on Liquidia to $32 From $16, Maintains Buy Rating
MT
Transcript : Liquidia Corporation, 2023 Earnings Call, Mar 13, 2024
Liquidia's 2023 Net Loss Widens, Revenue Increases -- Shares Advance Pre-Bell
MT
Liquidia Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update
GL
Certain Stock Units of Liquidia Corporation are subject to a Lock-Up Agreement Ending on 12-MAR-2024.
CI
Certain Warrants of Liquidia Corporation are subject to a Lock-Up Agreement Ending on 12-MAR-2024.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LQDA Stock
  4. News Liquidia Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW